Impact of Virtual Reality on Peri-interventional Pain, Anxiety and Distress in a Pediatric Oncology Outpatient Clinic
Launched by HANNOVER MEDICAL SCHOOL · Jan 23, 2024
Trial Information
Current as of July 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 6-18 years
- • any sex
- • port puncture or placement of a peripheral venous catheter in pediatric outpatient clinic
- • hematological or oncological diagnosis
- • informed consent
- Exclusion Criteria:
- • epilepsy
- • coronary artery disease
- • history of severe vertigo
- • obstacles to putting on and wearing VR glasses
- • lack of informed consent for study participation.
About Hannover Medical School
Hannover Medical School (Medizinische Hochschule Hannover, MHH) is a leading academic medical institution in Germany, renowned for its commitment to innovative research and high-quality clinical care. Established in 1965, MHH specializes in a wide range of medical disciplines, with a strong focus on transplantation medicine, regenerative medicine, and personalized healthcare. The institution actively participates in clinical trials to advance medical knowledge and develop cutting-edge therapies, leveraging its state-of-the-art facilities and collaborative environment. With a dedicated team of researchers, clinicians, and support staff, Hannover Medical School aims to translate scientific findings into practical applications that improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hanover, Lower Saxony, Germany
Patients applied
Trial Officials
Urs Mücke, Dr.
Principal Investigator
Hannover Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported